![](/img/cover-not-exists.png)
Benefit from a high dose of gefitinib in a woman with lung adenocarcinoma and an epidermal growth factor receptor tyrosine-kinase acquired mutation
Fontanini, Gabriella, Melfi, Franca, Boldrini, Laura, Prochilo, Tiziana, Baldini, EdittaLanguage:
english
Journal:
Molecular Medicine Reports
DOI:
10.3892/mmr.1.1.41
Date:
January, 2008
File:
PDF, 170 KB
english, 2008